J. M. Gill

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

A. Winston, S. Taylor-Robinson, D. Cooper, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries

J. Sterne, A. Mocroft, M. Egger, 2015 .

Prognostic Importance of Anaemia in HIV Type-1-Infected Patients Starting Antiretroviral Therapy: Collaborative Analysis of Prospective Cohort Studies

Ross J. Harris, J. Sterne, A. Mocroft, 2008, Antiviral Therapy.

Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy

A. Winston, S. Taylor-Robinson, D. Cooper, 2012, Neuroradiology.

Differences in the Direction of Change of Cerebral Function Parameters Are Evident over Three Years in HIV-Infected Individuals Electively Commencing Initial cART

A. Winston, S. Taylor-Robinson, D. Cooper, 2015, PLoS ONE.